Concepedia

Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide

Lauriane Goldwirt, Kévin Beccaria, Alexandre Carpentier, Ahmed Idbaïh, Charlotte Schmitt, Camille Levasseur, Marianne Labussière, Aline Milane, Robert Farinotti, Christine Fernandez

Journal of Neuro-Oncology · 2015 · 15 citations · 40 references

DOI

Concepts

References

40

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

, , +12

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

K. Jin Kim, Bing Li, Jane Winer et al. · Nature · 1993 · 3.6K citations

, , +14

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text

, , +17

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

Olivier Chinot, Wolfgang Wick, Warren Mason et al. · New England Journal of Medicine · 2014 · 2.5K citations · Full text

, , +15

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Carlos Cordon‐Cardo, James P. O’Brien, D Casals et al. · Proceedings of the National Academy of Sciences · 1989 · 1.7K citations · Full text

, , +16